The NEO (NEOADJUVANT ENDOCRINE OUTCOMES) TRIAL: Neoadjuvant Endocrine Therapy for Primary Breast Cancer: Investigation of Clinical and Translational Outcomes
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Anastrozole (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms NEO
- 07 Feb 2014 Status changed from active, no longer recruiting to completed according to ClinicalTrial.gov record.
- 12 Nov 2013 New trial record